ACAD Market Cap & Key Metrics
ACADIA Pharmaceuticals Inc.
$19.78
+$0.20(+1.02%)
50
Overall
75
Value
9
Tech
68
Quality
Market Cap
$3.37B
Volume
1.47M
52W Range
$19.59 - $30.96
Target Price
$32.15
ACAD market cap is $3.37B. This page lists ACADIA Pharmaceuticals Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
ACAD Key Metrics
- Market cap
- $3.37B
- P/E ratio (current-year EPS estimate)
- 30.91
- EPS estimate, current year
- $0.64
- EPS growth, 3-year
- +55.10%
- Value score
- 75
- Quality score
- 68
- Technical score
- 9
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.07B | $957.80M | $726.44M | $517.24M | $484.14M |
| EBITDA | $118.97M | $248.48M | -$62.68M | -$211.44M | -$167.09M |
| EPS | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $19.78 | +1.0% | 1.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW